Item 8.01. Other Events.
On January 10, 2022, Global Blood Therapeutics, Inc. issued a press release
titled "Oxbryta® (voxelotor) Tablets for Oral Suspension, A New Dispersible
Tablet Dosage Form, Now Available for Patients with Sickle Cell Disease in the
United States." A copy of the press release is attached as Exhibit 99.1 to this
Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
99.1 Press Release dated January 10, 2022
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
© Edgar Online, source Glimpses